Teva Pharmaceuticals USA has recalled 26,233 units of AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder due to concerns that the devices are subpotent. Testing revealed that the delivered dose of salmeterol was below the required levels specified on the label. The recall includes various strengths of both prescription and sample inhalers distributed to pharmacies and healthcare providers nationwide.
A subpotent inhaler may not deliver the full amount of medication required to manage asthma symptoms. If a patient receives a lower dose of salmeterol than intended, they may experience a worsening of their condition or inadequate relief during respiratory distress. No injuries or incidents have been reported in connection with this issue.
You have 2 options:
Quantity: 10,665 inhalers
Quantity: 3,240 inhalers
Quantity: 1,978 inhalers
Quantity: 4,850 inhalers
Quantity: 5,500 inhalers
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.